With a new imaging technique, scientists discover an ecosystem that determines how eggs mature and ovaries age. The ticking of the biological clock is especially loud in the ovaries — the organs that ...

Ovarian cancer is known for its aggressive spread, often targeting fatty tissues in the abdomen. Now, a study published in Nature Communications by researchers at Karolinska Institutet and Queen Mary ...

Jessica Gilbert is on a mission to raise awareness of ovarian cancer. An Ohio mom is opening up about being diagnosed with ovarian cancer after initially thinking she had a sinus infection. In January ...

This story has been modified to correct that Lynparza was an FDA-approved maintenance drug. BOSTON — Christine Croughwell has often felt alone since being diagnosed with Stage 4 ovarian cancer. Now ...

LEXINGTON, Ky. (WKYT) - For nearly 40 years, a program through UK HealthCare has been working to save lives by providing free screenings. Ovarian cancer is hard to detect, and its symptoms are often ...

Carla Peoples says she'd been “totally healthy” all her life when she noticed subtle changes in her body. There was some bloating that progressed to the point where it caused her belly stick out. “I ...

Since 2023, a rumor has spread online spread that some jobs carried a higher risk of ovarian cancer. For example, one post on X said accounting and hairdressing were two of the jobs linked to a higher ...

AWARENESS MONTH, AND LSU HEALTH WANTS TO MAKE SURE ALL OF THE LADIES IN LOUISIANA ARE HAPPY AND HEALTHY, AND THEY’VE GOT AN UPCOMING EVENT RAISING MONEY TO SUPPORT THE IMPORTANT CANCER CARE SOME WOMEN ...

September is National Ovarian Cancer Awareness Month, a reminder of the importance of knowing the symptoms, talking with your doctor, and taking preventative steps. Ovarian cancer is the deadliest of ...

1 Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China 2 Department of Pathology, Longhua Hospital, Shanghai University of Traditional ...

Relacorilant targets glucocorticoid receptor proteins, potentially redefining treatment for platinum-resistant ovarian cancer by inhibiting cancer cell proliferation. Clinical trials show relacorilant ...

PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.